HyTest is a leading producer of antibodies and antigens for the in vitro diagnostic (IVD) industry. The growing company operates in a global market where growth is driven by an aging population, innovation and increasing investments in medical care.
Through its strong market position, HyTest may have a significant impact on patient outcomes for a large group of people in developed and developing economies alike. Through its leading R&D and product suite, the company is well positioned to drive future innovation in its industry.
Aging population, advances in research and technology, and the global trend of increased investments in medical care and wellness drives the need for high quality antibodies and antigens, which are key components in various laboratory assays and diagnostic kits.
How do we solve it?
By leveraging the latest research and state-of-theart technology, HyTest brings exceptional quality and innovation to the IVD industry. This contributes to improve health and patient outcomes globally
How do we improve?
Through focusing on R&D, improved technology and global expansion, the company can foster industry innovation, broaden its reach and improve health for a larger group of people.
Helping the IVD industry with innovation and consistently delivering world class antibodies and antigens assists in the accuracy of IVD tests and thus patient outcomes. By broadening the company’s footprint, HyTest can increase its impact further.